Home » Topics » BioWorld Science

BioWorld Science
RSS

Carbon Biosciences raises series A financing to advance cystic fibrosis program toward clinic

June 22, 2022

Cardiac myosin inhibitors described by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

June 22, 2022

Chengdu Baiyu Pharmaceutical patents protein mono-ADP-ribosyltransferase TIPARP inhibitors

June 22, 2022

Roche describes new hepatitis B virus HBsAg and HBeAg inhibitors

June 22, 2022

Chengdu Cynogen Bio-Pharmaceutical Technology presents new CDK inhibitors

June 22, 2022

New GLP-1 receptor agonists identified at Shenzhen Salubris Pharmaceuticals

June 22, 2022

KLF5 as novel therapeutic target to reduce tumorigenic GBM phenotype

June 22, 2022

[68Ga]DOTA-ECL1i PET imaging in pancreatic cancer metastasis

June 22, 2022

Use of [177Lu]Lu-CCZ01158 shows promise for the treatment of human melanoma

June 21, 2022

miR-662 revealed as a metastatis-to-bone marker in breast cancer

June 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...